124 related articles for article (PubMed ID: 3575357)
1. Neurochemical and behavioral effects of N-ethyl-acetylcholine aziridinium chloride in mice.
Pope CN; Ho BT; Wright AA
Pharmacol Biochem Behav; 1987 Feb; 26(2):365-71. PubMed ID: 3575357
[TBL] [Abstract][Full Text] [Related]
2. Passive avoidance deficits in mice following ethylcholine aziridinium chloride treatment.
Pope CN; Englert LF; Ho BT
Pharmacol Biochem Behav; 1985 Feb; 22(2):297-9. PubMed ID: 3983221
[TBL] [Abstract][Full Text] [Related]
3. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro.
Lautenschlager M; Onufriev MV; Gulyaeva NV; Harms C; Freyer D; Sehmsdorf U; Ruscher K; Moiseeva YV; Arnswald A; Victorov I; Dirnagl U; Weber JR; Hörtnagl H
Neuroscience; 2000; 97(2):383-93. PubMed ID: 10799770
[TBL] [Abstract][Full Text] [Related]
5. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates.
Chrobak JJ; Hanin I; Schmechel DE; Walsh TJ
Brain Res; 1988 Oct; 463(1):107-17. PubMed ID: 3196899
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
Emerich DF; Walsh TJ
Brain Res; 1990 Sep; 527(2):299-307. PubMed ID: 2253037
[TBL] [Abstract][Full Text] [Related]
7. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task.
Chrobak JJ; Hanin I; Walsh TJ
Brain Res; 1987 Jun; 414(1):15-21. PubMed ID: 3620916
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices.
Leventer S; McKeag D; Clancy M; Wulfert E; Hanin I
Neuropharmacology; 1985 May; 24(5):453-9. PubMed ID: 3839570
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal electrical activity in relation to behavior following ethylcholine aziridinium ion (AF64A) treatment.
Stewart DJ; Leventer SM; Hanin I; Vanderwolf CH
Pharmacol Biochem Behav; 1987 Feb; 26(2):357-64. PubMed ID: 3575356
[TBL] [Abstract][Full Text] [Related]
10. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
el Tamer A; Corey J; Wülfert E; Hanin I
Neuropharmacology; 1992 Apr; 31(4):397-402. PubMed ID: 1522957
[TBL] [Abstract][Full Text] [Related]
11. Cholinotoxicity induced by ethylcholine aziridinium ion after intracarotid and intracerebroventricular administration.
Pittel Z; Fisher A; Heldman E
Life Sci; 1989; 44(20):1437-48. PubMed ID: 2725177
[TBL] [Abstract][Full Text] [Related]
12. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Leventer SM; Wulfert E; Hanin I
Neuropharmacology; 1987 Apr; 26(4):361-5. PubMed ID: 3587537
[TBL] [Abstract][Full Text] [Related]
13. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Berger ML; Havelec L; Hornykiewicz O
J Neurosci; 1993 Jul; 13(7):2939-45. PubMed ID: 7687281
[TBL] [Abstract][Full Text] [Related]
14. Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin?
McGurk SR; Hartgraves SL; Kelly PH; Gordon MN; Butcher LL
Neuroscience; 1987 Jul; 22(1):215-24. PubMed ID: 3627443
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A.
Emerich DF; Black BA; Kesslak JP; Cotman CW; Walsh TJ
Brain Res Bull; 1992 Feb; 28(2):219-26. PubMed ID: 1596741
[TBL] [Abstract][Full Text] [Related]
16. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
Fisher A; Mantione CR; Abraham DJ; Hanin I
J Pharmacol Exp Ther; 1982 Jul; 222(1):140-5. PubMed ID: 6896342
[TBL] [Abstract][Full Text] [Related]
17. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical effects of intraventricular AF64A administration in rats.
Jarrard LE; Kant GJ; Meyerhoff JL; Levy A
Pharmacol Biochem Behav; 1984 Aug; 21(2):273-80. PubMed ID: 6548313
[TBL] [Abstract][Full Text] [Related]
19. Improving effect of acetylcholine receptor agonists on a deficit of 2-deoxyglucose uptake in cerebral cortical and hippocampal slices in aged and AF64A-treated rats.
Shibata S; Kodama K; Koga Y; Ueki S; Watanabe S
Brain Res; 1993 Feb; 603(2):248-54. PubMed ID: 8461979
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and behavioral effects of intrahippocampal AF64A in rats.
Blaker WD; Goodwin SD
Pharmacol Biochem Behav; 1987 Oct; 28(2):157-63. PubMed ID: 3685051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
